In for a Penny, in for a Pound: Methylphenidate reduces the inhibitory effect of high stakes on persistent risky choice

Journal of Neuroscience

Volumn 32, Issue 38, 2012, Pages 13032-13038

  Campbell Meiklejohn, Daniel ^a,b   Simonsen, Arndis ^a   Scheel Krüger, Jørgen ^a   Wohlert, Victoria ^a   Gjerløff, Trine ^a   Frith, Chris D ^a,c,d   Rogers, Robert D ^e   Roepstorff, Andreas ^a   Møller, Arne ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b NEW YORK UNIVERSITY   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ALL SOULS COLLEGE   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ADULT; ANXIETY; ARTICLE; COMPETITIVE BEHAVIOR; CONTROLLED STUDY; DECISION MAKING; DOUBLE BLIND PROCEDURE; FEMALE; HIGH RISK BEHAVIOR; HUMAN; HUMAN EXPERIMENT; MONEY; MOOD DISORDER; NORMAL HUMAN; PATHOLOGICAL GAMBLING; PLAY; PRIORITY JOURNAL; REINFORCEMENT; REWARD; TASK PERFORMANCE;

ADULT; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; DECISION MAKING; DOUBLE-BLIND METHOD; FEMALE; GAMES, EXPERIMENTAL; HUMANS; INHIBITION (PSYCHOLOGY); MALE; METHYLPHENIDATE; MOTIVATION; PERSONALITY; PROBABILITY; REACTION TIME; REWARD; RISK-TAKING; TASK PERFORMANCE AND ANALYSIS; YOUNG ADULT;

EID: 84866377196     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0151-12.2012     Document Type: Article

References (51)

1. Bates D, Maechler M (2009) Linear mixed-effects models using S4 classes. In: R package version 0.999375-45. Vienna, Austria: R Foundation.
2. Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AF, Kelley AE, Schmeichel B, Hamilton C, Spencer RC (2006) Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 60:1111-1120. CrossRef Medline
3. Binswanger HP (1981) Attitudes toward risk: theoretical implications of an experiment in rural India. Econ J 91:867-890. CrossRef
4. Bland RC, Newman SC, Orn H, Stebelsky G (1993) Epidemiology of pathological gambling in Edmonton. Can J Psychiatry 38:108-112. Medline
5. Campbell-Meiklejohn DK, Woolrich MW, Passingham RE, Rogers RD (2008) Knowing when to stop: the brain mechanisms of chasing losses. Biol Psychiatry 63:293-300. CrossRef Medline
6. Campbell-Meiklejohn D, Wakeley J, Herbert V, Cook J, Scollo P, Ray MK, Selvaraj S, Passingham RE, Cowen P, Rogers RD (2011) Serotonin and dopamine play complementary roles in gambling to recover losses. Neuropsychopharmacology 36:402-410. CrossRef Medline
7. Carver CS, White TL (1994) Behavioral-inhibition, behavioral activation, and affective responses to impending reward and punishment-the BIS BAS scales. J Pers Soc Psychol 67:319-333. CrossRef
8. Clatworthy PL, Lewis SJ, Brichard L, Hong YT, Izquierdo D, Clark L, Cools R, Aigbirhio FI, Baron JC, Fryer TD, Robbins TW (2009) Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory. J Neurosci 29:4690-4696. CrossRef Medline
9. Cools R, Barker RA, Sahakian BJ, Robbins TW (2001) Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex 11:1136-1143. CrossRef Medline
10. Cools R, Altamirano L, D'Esposito M (2006) Reversal learning in Parkinson's disease depends on medication status and outcome valence. Neuropsychologia 44:1663-1673. CrossRef Medline
11. Cubitt R, Starmer C, Sugden R (1998) On the validity of the random lottery incentive system. Exp Econ 1:115-131. CrossRef
12. DeVito EE, Blackwell AD, Kent L, Ersche KD, Clark L, Salmond CH, Dezsery AM, Sahakian BJ (2008) The effects of methylphenidate on decision making in attention-deficit/hyperactivity disorder. Biol Psychiatry 64: 636-639. CrossRef Medline
13. Field A (2009) Discovering statistics using SPSS. London: SAGE.
14. Fog R (1969) Stereotyped and non-stereotyped behaviour in rats induced by various stimulant drugs. Psychopharmacologia 14:299-304. CrossRef Medline
15. Frank MJ, Seeberger LC, O'reilly RC (2004) By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 306:1940-1943. CrossRef Medline
16. Gamo NJ, Wang M, Arnsten AF (2010) Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors. J Am Acad Child Adolesc Psychiatry 49:1011-1023. CrossRef Medline
17. Holt C, Laury S (2002) Risk aversion and incentive effects. Am Econ Rev 92:1644-1655. CrossRef
18. Holt C, Laury S (2005) Risk aversion and incentive effects: new data without order effects. Am Econ Rev 95:902-904. CrossRef
19. Juliusson A (2006) Optimism as modifier of escalation of commitment. Scand J Psychol 47:345-348. CrossRef Medline
20. Kahneman D, Tversky A (2000) Choices, values, and frames. Cambridge, UK: Cambridge UP.
21. Knutson B, Bjork JM, Fong GW, Hommer D, Mattay VS, Weinberger DR (2004) Amphetamine modulates human incentive processing. Neuron 43:261-269. CrossRef Medline
22. Leeman RF, Potenza MN (2012) Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity. Psychopharmacology (Berl) 219:469-490. CrossRef
23. Lesieur H (1984) The chase: career of the compulsive gambler. Rochester, Vermont: Schenkman Books.
24. Lesieur HR, Blume SB (1987) The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 144:1184-1188. Medline
25. O'Connor J, Dickerson M (2003) Definition and measurement of chasing in off-course betting and gaming machine play. J Gambl Stud 19:359-386. CrossRef Medline
26. Rahman S, Robbins TW, Hodges JR, Mehta MA, Nestor PJ, Clark L, Sahakian BJ (2006) Methylphenidate ("Ritalin") can ameliorate abnormal risktaking behavior in the frontal variant of frontotemporal dementia. Neuropsychopharmacology 31:651-658. CrossRef Medline
27. Raylu N, Oei TP (2004) The Gambling Related Cognitions Scale (GRCS): development, confirmatory factor validation and psychometric properties. Addiction 99:757-769. CrossRef Medline
28. Robbins TW, Arnsten AF (2009) The neuropsychopharmacology of frontoexecutive function: monoaminergic modulation. Annu Rev Neurosci 32: 267-287. CrossRef Medline
29. Rogers RD, Wielenberg B, Wojtecki L, Elben S, Campbell-Meiklejohn D, Schnitzler A (2011) Deep brain stimulation of the subthalamic nucleus transiently enhances loss-chasing behaviour in patients with Parkinson's Disease. Exp Neurol 231:181-189. CrossRef Medline
30. Scheel-Kruger J (1972) Behavioural and biochemical comparison of amphetamine derivatives, cocaine, benztropine and tricyclic anti-depressant drugs. Eur J Pharmacol 18:63-73. CrossRef Medline
31. Shiels K, Hawk LW Jr, Reynolds B, Mazzullo RJ, Rhodes JD, Pelham WE Jr, Waxmonsky JG, Gangloff BP (2009) Effects of methylphenidate on discounting of delayed rewards in attention deficit/hyperactivity disorder. Exp Clin Psychopharmacol 17:291-301. CrossRef Medline
32. Smith ME, Farah MJ (2011) Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychol Bull 137:717-741. CrossRef Medline
33. Spielberger CD (1970) STAI manual. Washington, DC: Consulting Psychologists Press.
34. Staw BM (1981) The escalation of commitment: a review and analysis. Acad Manage Rev 6:577-587. CrossRef
35. Staw BM (1996) The escalation of commitment: an update and appraisal. In: Organizational decision making (Shapira Z, ed), pp 191-215. Cambridge: Cambridge UP.
36. St Onge JR, Floresco SB (2009) Dopaminergic modulation of risk-based decision making. Neuropsychopharmacology 34:681-697. CrossRef Medline
37. St Onge JR, Chiu YC, Floresco SB (2010) Differential effects of dopaminergic manipulations on risky choice. Psychopharmacology (Berl) 211:209-221. CrossRef
38. Volberg RA, Steadman HJ (1988) Refining prevalence estimates of pathological gambling. Am J Psychiatry 145:502-505. Medline
39. Volkow ND, Wang G, Fowler JS, Logan J, Gerasimov M, Maynard L, Ding Y, Gatley SJ, Gifford A, Franceschi D (2001) Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 21:RC121. Medline
40. Volkow ND, Wang GJ, Fowler JS, Logan J, Jayne M, Franceschi D, Wong C, Gatley SJ, Gifford AN, Ding YS, Pappas N (2002) Nonhedonic food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect. Synapse 44:175-180. CrossRef Medline
41. Volkow ND, Wang GJ, Fowler JS, Telang F, Maynard L, Logan J, Gatley SJ, Pappas N, Wong C, Vaska P, Zhu W, Swanson JM (2004) Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatry 161:1173-1180. CrossRef Medline
42. Voon V, Pessiglione M, Brezing C, Gallea C, Fernandez HH, Dolan RJ, Hallett M (2010) Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron 65:135-142. CrossRef Medline
43. Voon V, Schoerling A, Wenzel S, Ekanayake V, Reiff J, Trenkwalder C, Sixel-Döring F (2011) Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome. BMC Neurol 11: 117. CrossRef Medline
44. Watson D, Clark LA, Tellegen A (1988) Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 54:1063-1070. CrossRef Medline
45. Wechsler D (2005) Wechsler Adult Intelligence Scale, Danish version III edition. Boston, MA: Pearson Assessment.
46. Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67:589-595. CrossRef Medline
47. Wilens TE (2008) Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 28:S46-S53. CrossRef Medline
48. Winstanley CA, Cocker PJ, Rogers RD (2011) Dopamine modulates reward expectancy during performance of a slot machine task in rats: evidence for a "near-miss" effect. Neuropsychopharmacology 36:913-925. CrossRef Medline
49. Zack M, Poulos CX (2004) Amphetamine primes motivation to gamble and gambling-related semantic networks in problem gamblers. Neuropsychopharmacology 29:195-207. CrossRef Medline
50. Zack M, Poulos CX (2009) Parallel roles for dopamine in pathological gambling and psychostimulant addiction. Curr Drug Abuse Rev 2:11-25. Medline
51. Zeeb FD, Robbins TW, Winstanley CA (2009) Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task. Neuropsychopharmacology 34:2329-2343. CrossRef Medline